Home/Filings/4/0001127602-25-007538
4//SEC Filing

McDermott Wendy 4

Accession 0001127602-25-007538

CIK 0001062822other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:33 PM ET

Size

15.7 KB

Accession

0001127602-25-007538

Insider Transaction Report

Form 4
Period: 2025-02-28
McDermott Wendy
SVP, Human Resources
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-28+18,94371,637 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-2827,69627,697 total
    Common Stock (27,696 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-2852,317104,633 total
    Common Stock (52,317 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-28+52,317151,650 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-2818,9430 total
    Common Stock (18,943 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-28+27,69699,333 total
  • Tax Payment

    Common Stock

    2025-02-28$0.67/sh30,004$20,103121,646 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
  • [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.

Issuer

LEXICON PHARMACEUTICALS, INC.

CIK 0001062822

Entity typeother

Related Parties

1
  • filerCIK 0001902760

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:33 PM ET
Size
15.7 KB